Bioreactors in tissue engineering - principles, applications and commercial constraints

被引:67
作者
Hansmann, Jan [1 ]
Groeber, Florian [2 ]
Kahlig, Alexander [2 ]
Kleinhans, Claudia [2 ]
Walles, Heike [1 ,3 ]
机构
[1] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, Stuttgart, Germany
[2] Univ Stuttgart, Inst Interfacial Engn IGVT, D-70569 Stuttgart, Germany
[3] Univ Wurzburg, Inst Tissue Engn & Regenerat Med, Wurzburg, Germany
关键词
Applications; Bioreactor; Commercial Aspects; Red/medical biotechnology; Tissue engineering; MESENCHYMAL STEM-CELLS; FLOW PERFUSION BIOREACTOR; BED SYSTEM BIOREACTOR; BONE TISSUE; IN-VITRO; SUSPENSION-CULTURE; SHEAR-STRESS; OSTEOGENIC DIFFERENTIATION; VESSEL BIOREACTOR; FLASK BIOREACTOR;
D O I
10.1002/biot.201200162
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bioreactor technology is vital for tissue engineering. Usually, bioreactors are used to provide a tissue-specific physiological in vitro environment during tissue maturation. In addition to this most obvious application, bioreactors have the potential to improve the efficiency of the overall tissue-engineering concept. To date, a variety of bioreactor systems for tissue-specific applications have been developed. Of these, some systems are already commercially available. With bioreactor technology, various functional tissues of different types were generated and cultured in vitro. Nevertheless, these efforts and achievements alone have not yet led to many clinically successful tissue-engineered implants. We review possible applications for bioreactor systems within a tissue-engineering process and present basic principles and requirements for bioreactor development. Moreover, the use of bioreactor systems for the expansion of clinically relevant cell types is addressed. In contrast to cell expansion, for the generation of functional three-dimensional tissue equivalents, additional physical cues must be provided. Therefore, bioreactors for musculoskeletal tissue engineering are discussed. Finally, bioreactor technology is reviewed in the context of commercial constraints.
引用
收藏
页码:298 / 307
页数:10
相关论文
共 109 条
[1]  
Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI 10.1089/ten.TEA.2010.0014
[2]   Engineering growing tissues [J].
Alsberg, E ;
Anderson, KW ;
Albeiruti, A ;
Rowley, JA ;
Mooney, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12025-12030
[3]   Cell differentiation by mechanical stress [J].
Altman, GH ;
Horan, RL ;
Martin, I ;
Farhadi, J ;
Stark, PRH ;
Volloch, V ;
Richmond, JC ;
Vunjak-Novakovic, G ;
Kaplan, DL .
FASEB JOURNAL, 2001, 15 (14) :270-+
[4]   Design and characterization of a rotating bed system bioreactor for tissue engineering applications [J].
Anton, Fabienne ;
Suck, Kirstin ;
Diederichs, Solvig ;
Behr, Larissa ;
Hitzmann, Bernd ;
van Griensven, Martijn ;
Scheper, Thomas ;
Kasper, Cornelia .
BIOTECHNOLOGY PROGRESS, 2008, 24 (01) :140-147
[5]   The Regulation of Differentiation in Mesenchymal Stem Cells [J].
Augello, Andrea ;
De Bari, Cosimo .
HUMAN GENE THERAPY, 2010, 21 (10) :1226-1238
[6]   Design of a flow perfusion bioreactor system for bone tissue-engineering applications [J].
Bancroft, GN ;
Sikavitsas, VI ;
Mikos, AG .
TISSUE ENGINEERING, 2003, 9 (03) :549-554
[7]  
Begley CM, 2000, BIOTECHNOL BIOENG, V70, P32, DOI 10.1002/1097-0290(20001005)70:1<32::AID-BIT5>3.0.CO
[8]  
2-V
[9]   Resorbable biomaterials as bone graft substitutes [J].
Bohner, Marc .
MATERIALS TODAY, 2010, 13 (1-2) :24-30
[10]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650